Notification for Coronary Artery Calcification
(PICTURE Trial)
Trial Summary
What is the purpose of this trial?
This is a prospective randomized controlled trial assessing the impact of notifying patients and their clinicians of an incidental finding of coronary artery calcification (CAC) indicating increased cardiovascular risk. Patients will be identified through completed radiology orders for non-gated, non-contrast chest CT in the appropriate clinical context and then will have an EHR screen for inclusion criteria. The presence of CAC will be confirmed by a board-certified physician. Eligible patients will be randomized to CAC notification or usual care using a 1:1 stratified block randomization method based on baseline statin use.
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop taking your current medications. However, if you are on statin or non-statin lipid-lowering therapy, you are not eligible to participate.
What data supports the effectiveness of the treatment Notification for Coronary Artery Calcification?
The research suggests that using automated notification systems can improve communication of critical test results, which may enhance patient safety and reduce errors. While not directly related to coronary artery calcification, these systems have been effective in ensuring timely communication of important medical information.12345
Research Team
Fatima Rodriguez, MD
Principal Investigator
Stanford University
Eligibility Criteria
The PICTURE trial is for adults aged 18 to under 85 who've had a non-gated chest CT scan showing coronary artery calcification, and have seen a Stanford-affiliated clinician since January 1, 2020. It's not for those already on cholesterol-lowering meds, with advanced cancer, without active primary care at Stanford Health Care, outside the age range, or with statin allergies.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Randomization and Notification
Eligible patients are randomized to either CAC notification or usual care. Notification involves sending a standardized message to the patient's clinician and, after a delay, to the patient.
Follow-up
Participants are monitored for changes in statin prescription rates and healthcare resource use.
Treatment Details
Interventions
- Notification
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor